fluorexon has been researched along with CKD-MBD in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, H; Okada, S; Takeuchi, K; Yukihiro, S | 1 |
1 other study(ies) available for fluorexon and CKD-MBD
| Article | Year |
|---|---|
Experimental osteodystrophy of chronic renal failure induced by aluminum- and ferric-nitrilotriacetate in Wistar rats.
Topics: Animals; Chronic Kidney Disease-Mineral and Bone Disorder; Ferric Compounds; Fluoresceins; Kidney; Male; Nitrilotriacetic Acid; Rats; Rats, Wistar; Tibia; Weight Gain | 1995 |